in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
the uk�s initial plan had been challenged in court by the
.
chess grandmasters show the same longevity advantage as elite athletes